Ge Longhui, January 30 | Haochen Medical (002622.SZ) announced the 2023 annual results forecast, with operating income of 70,000,000 yuan to 78,0000 million yuan for the reporting period; net profit loss attributable to shareholders of listed companies of 170.01 million yuan to 90 million yuan, loss of 256.787 million yuan for the same period last year; net profit loss after deducting non-recurring profit and loss of 14,500,000 yuan - 75.0 million yuan, loss of 915.25 million yuan for the same period last year; basic earnings loss per share 0.2024 yuan/share — 0.1071 yuan/share.
During the reporting period, the company continued to strengthen market expansion, optimize product structure, and improve operational efficiency. The operating income of the dental medical service and permanent magnet switch business all increased. In particular, the revenue from dental medical services increased dramatically. Based on the long-term equity investment situation, the company conducted an impairment test on long-term equity investments. It is estimated that the recoverable amount of some investments is lower than the book value. Based on the principle of prudence, it is proposed to prepare for impairment of long-term equity investments, so the company's overall performance for 2023 was lost.